• Profile
Close

Population-level impact of infant 10-valent pneumococcal conjugate vaccination on adult pneumonia hospitalisations in Finland

Thorax Oct 12, 2017

Okasha O, et al. - This study analyzed national trends in pneumococcal and all-cause pneumonia hospitalisations in adults aged ≥18 years, before and after infant 10-valent pneumococcal conjugate vaccine (PCV10) introduction in 2010. Findings demonstrated that infant PCV10 programme, affording herd protection, has not only reversed the increasing trend but also caused a substantial decline in all-cause pneumonia hospitalisations in adults, specifically the elderly.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay